PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD...

16
HTAI MEETING – RIO 2011 HTA BASED ON HEALTH CARE SYSTEM EFFICIENCY: USING REAL- LIFE DATA TO IMPROVE HEALTH CARE MANAGEMENT SETTING THE GROUND PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD DE BUENOS AIRES

Transcript of PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD...

Page 1: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

HTAI MEETING – RIO 2011

HTA BASED ON HEALTH CARE SYSTEM EFFICIENCY: USING REAL-

LIFE DATA TO IMPROVE HEALTH CARE MANAGEMENT

SETTING THE GROUND

PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD.

INSTITUTO DE EFECTIVIDAD CLÍNICA Y

SANITARIA

UNIVERSIDAD DE BUENOS AIRES

Page 2: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

A RACE WITH HURDLES

Seguridad

Eficacia

Calidad

Costo-

Efectividad

Impacto

Presupuestario

Then 4…

Usually 3..

…& 5?

Page 3: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

BMJ 2011;342:d2175 doi: 10.1136/bmj.d2175

Page 4: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

Page 5: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

DECISION MAKERS: PROXIMAL AND

DISTAL

Eichler HG. NATURE REVIEWS. April 2010.

Page 6: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

SOME DEFINITIONS

TERM EFFICACY RELATIVE

EFFICACY

EFFECTIVENES

S RELATIVE EFFECTIVENESS

DEFINITION:

EXTENT TO

WHICH AN

INTERVENTION

DOES MORE

GOOD THAN

HARM…

UNDER IDEAL

CIRCUMSTANCES

UNDER IDEAL CIRCUMSTANCES

, COMPARED TO

ONE OR MORE

ALTERNATIVE

INTERVENTONS

WHEN PROVIDED

UNDER THE USUAL

CIRCUMSTANCES

OF HEALTH CARE

PRACTICE

COMPARED TO

ONE OR MORE

INTERVENTION

ALTERNATIVES

WHEN PROVIDED

UNDER THE USUAL

CIRCUMSTANCES

OF HEALTH CARE

PRACTICE

KEY FEATURES RANDOMIZATION

(EXPLANATORY

RCTS)

RANDOMIZATION

(EXPLANATORY

RCTS)

OBSERVATIONAL OBSERVATIONAL

PRAGMATIC /

NATURALISTIC

RCT High Level Pharmaceutical Forum of the European Commission. Core principles on relative effectiveness. EC Pharmcacuetical Forum

website [online], http://ec.europa.eu/pharmaforum/docs/rea_principles_en.pdf (2008).

Page 7: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

CONCEPT AND PITFALLS OF RELATIVE EFFICACY

ASSESSMENT

Eichler HG. NATURE REVIEWS. April 2010.

Page 8: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

Eichler HG. NATURE REVIEWS. April 2010.

SOME ”NOT SO NUANCES” IN RCTS

Page 9: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

ADVANTAGES AND DISADVANTAGES OF KEY STUDY DESIGNS

Eichler HG. NATURE REVIEWS. April 2010.

Page 10: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

POTENTIAL GAINS FROM ADAPTIVE DESIGN TRIALS

Eichler HG. NATURE REVIEWS. April 2010.

Page 11: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

PARADIGM SHIFT?

Eichler HG. NATURE REVIEWS. April 2010.

Page 12: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

REAL LIFE EXAMPLE 1: ECONOMIC EVALUATION OF

PNEUMOCOCCAL VACCINE FOR IMSS

(INSTITUTO MEXICANO SEGURO SOCIAL)

Page 13: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

REAL LIFE EXAMPLE 2: HEMODIALYSIS AND PERITONEAL

DIALYSIS

Page 14: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

REAL LIFE EXAMPLE:

ECONOMIC EVALUATION

OF HPV VACCINE IN 5

LA COUNTRIES

Page 15: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

OBSERVATIONAL/REAL LIFE VS. EXPERIMENTAL…

•Lower blood pressure with drugs

•Lower LDL with statins

•Aspirin toprevent MI

•Mammograpy for breast cancer

Observations Proved True

•Hormonal Replacement Therapy (breast cancer, failed)

•Vitamins to prevent cancer/CVD (failed)

•Bone marrow transplant for breast cancer (higher death)

•Back surgery, kyphoplasty (marginal benefit)

…and Not

Thank you to Andrew Epstein and Michael Lauer

Page 16: PROF. FEDERICO AUGUSTOVSKI, MD, MSC, PHD ...bvsms.saude.gov.br/bvs/htai/documentos/Panel101FA.pdfFEDERICO AUGUSTOVSKI, MD, MSC, PHD. INSTITUTO DE EFECTIVIDAD CLÍNICA Y SANITARIA UNIVERSIDAD

Prof. Federico Augustovski

CONCLUSIONS

• DIFFERENT DATA AND REQUIREMENTS BY

DIFFERENT HEALTHCARE DECISION MAKERS

• EXPERIMENTAL DATA STILL KEY TO ACCOUNT

FOR ISSUES SUCH AS UNMEASURED CONFOUNDING

•EXCEPTIONS (HUGE EFFECT SIZES)

•INCREASING IMPORTANCE OF REAL LIFE

OBSERVATIONAL+/- EXPERIMENTAL DATA

TO INFORM HEALTH DECISIONS